Correlation Between ABVC Biopharma and Processa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Processa Pharmaceuticals, you can compare the effects of market volatilities on ABVC Biopharma and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Processa Pharmaceuticals.
Diversification Opportunities for ABVC Biopharma and Processa Pharmaceuticals
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ABVC and Processa is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Processa Pharmaceuticals go up and down completely randomly.
Pair Corralation between ABVC Biopharma and Processa Pharmaceuticals
Given the investment horizon of 90 days ABVC Biopharma is expected to generate 0.55 times more return on investment than Processa Pharmaceuticals. However, ABVC Biopharma is 1.82 times less risky than Processa Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 150.00 in ABVC Biopharma on August 24, 2024 and sell it today you would lose (95.00) from holding ABVC Biopharma or give up 63.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ABVC Biopharma vs. Processa Pharmaceuticals
Performance |
| Timeline |
| ABVC Biopharma |
| Processa Pharmaceuticals |
ABVC Biopharma and Processa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ABVC Biopharma and Processa Pharmaceuticals
The main advantage of trading using opposite ABVC Biopharma and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.| ABVC Biopharma vs. Lyra Therapeutics | ABVC Biopharma vs. Hookipa Pharma | ABVC Biopharma vs. Cingulate Warrants | ABVC Biopharma vs. SAB Biotherapeutics |
| Processa Pharmaceuticals vs. Lyra Therapeutics | Processa Pharmaceuticals vs. Hookipa Pharma | Processa Pharmaceuticals vs. Cingulate Warrants | Processa Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |